Experimental vaccine for Ebola indicates it's safe and effective

Experimental vaccine for Ebola confirmed safe and effective
Experimental vaccine for Ebola confirmed safe and effective | Courtesy of
An early stage clinical trial that tested the safety and effectiveness of the experimental Ebola vaccine VSV-ZEBOV provoked an immune response from all 40 of the healthy adults involved in the study, suggesting it safe for humans.

There were a few common side effects to the drug: pain at the injection site and a transient fever that dissolved between 12 and 36 hours after the subjects received their injections.

VSV-ZEBOV is just one of two experimental Ebola vaccines being tested in a Phase 2/3 PREVAIL clinical trial in Liberia.

“The ongoing Ebola outbreak in West Africa is unprecedented in scope and duration,” National Institute of Allergy and Infectious Diseases Director Anthony Fauci said. “The outbreak is slowly coming under control, thanks to extraordinary and multi-faceted efforts in the affected nations. However, there still are no licensed specific therapies or vaccines for Ebola. Until a safe and effective vaccine is available, the world will continue to be under-prepared for the next Ebola outbreak.”

The study, sponsored by the U.S. government and conducted at the National Institutes of Health and the Walter Reed Army Institute of Research, has been published online in The New England Journal of Medicine.

Organizations in this Story

National Institutes of Health Walter Reed Army Institute

Want to get notified whenever we write about any of these organizations ?
Next time we write about any of these organizations, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.